Neurological Diseases alzheimers Flashcards

1
Q

what is dementia defined as
some exapmles

A

progressive deterioration of cognitive function
short term memory loss
long term memory loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how is AD different from dementia

A

rapid cognitive decline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the clinical symptoms of AD

A

memory loss
abnormal behavouir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the main risk factor for AD

A

age
incidence doubles every 5 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how many people have dementia in the uk and how much does this cost the healthcare system

A

over 500 thousand
costs 35 billion a year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the pathological hallmarks of AD

A

amyloid plaques
intracellular neurofibrillary tangle
non fungible tokes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

between the two hallmarks of AD
which is intracellular and which is extracellular

A

amyloid plaques are extracellular and nfts are intracellular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are some of the theories behind AD pathogenesis

A

amyloid cascade hypothesis
tau and tangle hypothesis
mitochondrial dysfunction and ox stress hypothesis
cholinergic hypothesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the app in AD

A

large extracellular protein produced in large quantities in neurons
undergoes post translational processing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are the three secretases involved in the cleavage of app in AD

A

alpha beta and gamma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the two product catagories of amyloid secretases

A

pathogenic and non pathogenic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

which two secretases cleave app in non AD

A

alpha and gamma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the products formed by alpha secretase in the non amyloid in AD

A

alpha cleaves app to create soluble appa(released)
membrane associated c terminal fragment actf(c83)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the products formed by gamma secretase in non amyloid

A

gamma cleaves acft to make p3
and aicd

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the products formed in the amyloid process in AD

A

sappb
c terminal fragment beta(c99)

gamma secretase then cleaves beta cft to form beta amyloid peptide and aicd

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

why do beta amyloid peptides cause AD

A

increased formation and defectiv clearance of beta amyloid causes plaques
beta amyloid is neurotoxic

17
Q

what causes familal AD

A

mutations in app or secretases cause AD

18
Q

what are nfts formed from

A

intracellular aggregates of tau protein

19
Q

what is the tau protein in AD

A

a microtubule associated protein
promotes microtubule assembly
and maintains stability

20
Q

how is the binding of tau to microtubules mediated in AD

A

phosphorylation state

21
Q

what does hyperphosphorylation do to tau in AD

A

decreases its binding to microtubules
decreased binding leads to tau aggregation
causes confirmational changes and misfolds in protein structure

22
Q

what is cholinergic hypothesis for ad

A

the reduction in acetylcholine release leads to AD

23
Q

in AD why is there a reduction of ach synthesis

A

deficit in enzyme
ChAT choline acetyl transferase

reduction of ach in neuron depolarisation

reduction of ach reuptake

loss of cholinergic neurones

24
Q

what is the reasoning behind mitochondrial dysfunction theory of ad

A

dysfunction increases with age
which leads to compromised atp production and oxidative stress
contributes to neuronal death

25
Q

what are the two main drug classes used to treat ad

A

cholinesterase inhibitors
nmda receptor antagonist(MDMA)
cholinomimetic therapy
acetylcholinesterase inhibitors

26
Q

what to acetylcholinesterases inhibitors do

A

prevent breakdown of ACH
increase concentration
increase communication

27
Q

what neurotransmitter is released in later stages of AD

A

glutamate

28
Q

what can glutamate do in ad and which drug class counters this

A

can cause further damage
NMDA blocks glutamate